Baricitinib Successfully Treated a Teenager with Refractory Livedoid Vasculopathy: A Case Report and Literature Review
Successful treatment of this refractory patient with baricitinib provides another evidence for the potential therapeutic effect of JAK1/JAK2 inhibitors in LV, and also offers a reference for the dosage tapering regime of baricitinib in LV.
Authors
- Shengfang Bao (ORCID: https://orcid.org/0000-0001-5529-135X)
- Yanliang Jin
- Xiqiong Han
- Chenxi Liu (ORCID: https://orcid.org/0000-0003-0567-8032)
- Yingying Jin
- Xuemei Xu
- Hua Huang (ORCID: https://orcid.org/0000-0003-2626-3768)
- Liping Wang (ORCID: https://orcid.org/0000-0003-2746-8992)
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Children's Medical Center (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-02-01
- DOI
- https://doi.org/10.2147/jir.s495481
- Citations
- 3
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 4.87